362 related articles for article (PubMed ID: 1720259)
1. [What is the latest in anti-arrhythmia therapy?].
Gloor HO
Schweiz Med Wochenschr; 1991 Nov; 121(47):1711-4. PubMed ID: 1720259
[TBL] [Abstract][Full Text] [Related]
2. The Cardiac Arrhythmia Suppression Trial: Implications for nursing practice.
Kellen JC; Ettinger A; Todd L; Brezsnyak ML; Campion J; McBride R; Thomas S; Corum J; Schron E
Am J Crit Care; 1996 Jan; 5(1):19-25. PubMed ID: 8680488
[TBL] [Abstract][Full Text] [Related]
3. A critical appraisal of the cardiac arrhythmia suppression trial (CAST).
Naccarelli GV; Dougherty AH; Wolbrette D; Wiggins S
Appl Cardiopulm Pathophysiol; 1991; 4(1):9-16. PubMed ID: 10147539
[TBL] [Abstract][Full Text] [Related]
4. [Can sudden cardiac death be prevented by treatment with anti-arrhythmia drugs?].
Zrenner B; Koller B; Rudolph W
Herz; 1990 Apr; 15(2):90-102. PubMed ID: 2188895
[TBL] [Abstract][Full Text] [Related]
5. [New aspects of the clinical use of anti-arrhythmia agents with special reference to acute therapy of ventricular tachycardia (lidocaine vs. ajmaline)].
Manz M; Mletzko R; Jung W; Lüderitz B
Herz; 1990 Apr; 15(2):79-89. PubMed ID: 2188894
[TBL] [Abstract][Full Text] [Related]
6. Nonsustained ventricular tachycardia as a predictor for sudden death in patients with idiopathic dilated cardiomyopathy. The role of amiodarone treatment.
Castelli G; Ciaccheri M; Cecchi F; Troiani V; Nannini M; Marconi P; Olivotto J; Montereggi A; Dolara A
G Ital Cardiol; 1999 May; 29(5):514-23. PubMed ID: 10367218
[TBL] [Abstract][Full Text] [Related]
7. [Management of patients with risk of sudden death. The amiodarone example].
Djian J
Arch Mal Coeur Vaiss; 1994 Jan; 87(1 Spec No):67-74. PubMed ID: 7944868
[TBL] [Abstract][Full Text] [Related]
8. [Antiarrhythmic agents: current situation].
Bonhorst D
Rev Port Cardiol; 1995 May; 14(5):421-9, 362. PubMed ID: 7654403
[TBL] [Abstract][Full Text] [Related]
9. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure.
Singh SN; Fletcher RD; Fisher SG; Singh BN; Lewis HD; Deedwania PC; Massie BM; Colling C; Lazzeri D
N Engl J Med; 1995 Jul; 333(2):77-82. PubMed ID: 7539890
[TBL] [Abstract][Full Text] [Related]
10. [Combination anti-arrhythmic drug therapy].
Lüderitz B; Jung W; Manz M
Z Kardiol; 1992; 81 Suppl 4():157-61. PubMed ID: 1283933
[TBL] [Abstract][Full Text] [Related]
11. Antiarrhythmic agents for chronic ventricular arrhythmias.
Nestico PF; Morganroth J
Compr Ther; 1987 Apr; 13(4):26-35. PubMed ID: 3105950
[TBL] [Abstract][Full Text] [Related]
12. Predicting mortality after myocardial infarction from the response of RR variability to antiarrhythmic drug therapy.
Bigger JT; Rolnitzky LM; Steinman RC; Fleiss JL
J Am Coll Cardiol; 1994 Mar; 23(3):733-40. PubMed ID: 7509355
[TBL] [Abstract][Full Text] [Related]
13. Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction.
Cardiac Arrhythmia Suppression Trial (CAST) Investigators
N Engl J Med; 1989 Aug; 321(6):406-12. PubMed ID: 2473403
[TBL] [Abstract][Full Text] [Related]
14. [Long-term effect of amiodarone therapy following myocardial infarct in patients with complex ventricular arrhythmias].
Kiowski W; Brunner H; Pfisterer M; Burckhardt D; Burkart F
Schweiz Med Wochenschr; 1993 Mar; 123(12):533-6. PubMed ID: 8475360
[TBL] [Abstract][Full Text] [Related]
15. [Propafenone and flecainide in the therapy of ventricular arrhythmias].
Paperini L; Davini A; Lattanzi F; Topi A; Reisenhofer B; Squarcini G; Paci A; Topi PL
Minerva Cardioangiol; 1995 Oct; 43(10):449-57. PubMed ID: 8819814
[TBL] [Abstract][Full Text] [Related]
16. Interaction of baseline characteristics with the hazard of encainide, flecainide, and moricizine therapy in patients with myocardial infarction. A possible explanation for increased mortality in the Cardiac Arrhythmia Suppression Trial (CAST).
Anderson JL; Platia EV; Hallstrom A; Henthorn RW; Buckingham TA; Carlson MD; Carson PE
Circulation; 1994 Dec; 90(6):2843-52. PubMed ID: 7994829
[TBL] [Abstract][Full Text] [Related]
17. Treatment of ventricular arrhythmias after CAST.
Tonkin AM
Med J Aust; 1992 Apr; 156(7):488-92. PubMed ID: 1372950
[TBL] [Abstract][Full Text] [Related]
18. [Mishaps with anti-arrhythmic agents used to reduce mortality after infarction].
Funck-Brentano C
Rev Prat; 1992 Nov; 42(17):2175-8. PubMed ID: 1290040
[TBL] [Abstract][Full Text] [Related]
19. [How should ventricular arrhythmia be treated?].
Widimský J; Bytesník J
Vnitr Lek; 1991 May; 37(5):419-24. PubMed ID: 1842138
[TBL] [Abstract][Full Text] [Related]
20. What have clinical trials taught us about proarrhythmia?
Skanes AC; Green MS
Can J Cardiol; 1996 Apr; 12 Suppl B():20B-26B. PubMed ID: 8616725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
